Avram Michael J, Krejcie Tom C, Henthorn Thomas K, Niemann Claus U
Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Ward Bldg. 13-199, Chicago, IL 60611-3008, USA.
J Pharmacol Exp Ther. 2004 Nov;311(2):617-24. doi: 10.1124/jpet.104.070094. Epub 2004 Jun 14.
Beta-adrenergic receptor blockers decrease intravenous anesthetic dose requirements. The present study determined the effect of propranolol on indocyanine green and antipyrine disposition from the moment of rapid intravenous injection. Anti-pyrine is a physiological marker that distributes to a volume as large as total body water in a blood flow-dependent manner and is a pharmacokinetic surrogate for many lipophilic drugs, including intravenous anesthetics. Antipyrine and indocyanine green disposition were determined twice in five healthy adult males in this Institutional Review Board-approved study, once during propranolol infusion. After rapid indocyanine green and antipyrine injection, arterial blood samples were collected frequently for 2 min and less frequently thereafter. Plasma indocyanine green and antipyrine concentrations were measured by high-performance liquid chromatography. Indocyanine green and antipyrine disposition were characterized, using SAAM II, by a recirculatory pharmacokinetic model that describes drug disposition from the moment of injection. Parameters were compared using the paired t test. The disposition of indocyanine green demonstrated that propranolol decreased cardiac output at the expense of the fast peripheral (nonsplanchnic) intravascular circuit. The area under the antipyrine concentration versus time relationship was doubled for at least the first 3 min after injection due to both decreased cardiac output and maintenance of nondistributive blood flow at the expense of a two-thirds reduction of blood flow (intercompartmental clearance) to the rapidly equilibrating (fast, splanchnic) tissue volume. The increase in antipyrine area under the curve due to propranolol-induced alteration of initial antipyrine disposition could explain decreased intravenous anesthetic dose requirements in the presence of beta-adrenergic receptor blockade.
β-肾上腺素能受体阻滞剂可降低静脉麻醉药的剂量需求。本研究确定了普萘洛尔对快速静脉注射后吲哚菁绿和安替比林处置的影响。安替比林是一种生理标志物,以血流依赖的方式分布于与全身水一样大的容积中,是包括静脉麻醉药在内的许多亲脂性药物的药代动力学替代指标。在这项经机构审查委员会批准的研究中,对5名健康成年男性进行了两次吲哚菁绿和安替比林处置测定,一次是在输注普萘洛尔期间。快速注射吲哚菁绿和安替比林后,频繁采集动脉血样2分钟,此后采集频率降低。血浆吲哚菁绿和安替比林浓度通过高效液相色谱法测定。使用SAAM II,通过一个描述注射后药物处置的再循环药代动力学模型来表征吲哚菁绿和安替比林的处置。使用配对t检验比较参数。吲哚菁绿的处置表明,普萘洛尔以牺牲快速外周(非内脏)血管内循环为代价降低了心输出量。由于心输出量降低和非分布性血流的维持,以牺牲向快速平衡(快速、内脏)组织容积的血流(隔室间清除率)减少三分之二为代价,注射后至少前3分钟安替比林浓度与时间关系曲线下面积增加了一倍。普萘洛尔引起的初始安替比林处置改变导致的安替比林曲线下面积增加,可以解释在存在β-肾上腺素能受体阻滞的情况下静脉麻醉药剂量需求降低的原因。